Prof Peter Barlow P.Barlow@napier.ac.uk
Professor
Prof Peter Barlow P.Barlow@napier.ac.uk
Professor
Pavel Svoboda
Annie Mackellar
Anthony A. Nash
Ian A. York
Jan Pohl
Donald J. Davidson
Ruben O. Donis
The extensive world-wide morbidity and mortality caused by influenza A viruses highlights the need for new insights into the host immune response and novel treatment approaches. Cationic Host Defense Peptides (CHDP, also known as antimicrobial peptides), which include cathelicidins and defensins, are key components of the innate immune system that are upregulated during infection and inflammation. Cathelicidins have immunomodulatory and anti-viral effects, but their impact on influenza virus infection has not been previously assessed. We therefore evaluated the effect of cathelicidin peptides on disease caused by influenza A virus in mice. The human cathelicidin, LL-37, and the murine cathelicidin, mCRAMP, demonstrated significant anti-viral activity in vivo, reducing disease severity and viral replication in infected mice to a similar extent as the well-characterized influenza virus-specific antiviral drug zanamivir. In vitro and in vivo experiments suggested that the peptides may act directly on the influenza virion rather than via receptor-based mechanisms. Influenza virus-infected mice treated with LL-37 had lower concentrations of pro-inflammatory cytokines in the lung than did infected animals that had not been treated with cathelicidin peptides. These data suggest that treatment of influenza-infected individuals with cathelicidin-derived therapeutics, or modulation of endogenous cathelicidin production may provide significant protection against disease.
Barlow, P. G., Svoboda, P., Mackellar, A., Nash, A. A., York, I. A., Pohl, J., Davidson, D. J., & Donis, R. O. (2011). Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37. PLOS ONE, 6(10), Article e25333. https://doi.org/10.1371/journal.pone.0025333
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 1, 2011 |
Online Publication Date | Oct 21, 2011 |
Publication Date | Oct 21, 2011 |
Deposit Date | Mar 27, 2012 |
Publicly Available Date | Mar 27, 2012 |
Journal | PLoS One |
Print ISSN | 1932-6203 |
Electronic ISSN | 1932-6203 |
Publisher | Public Library of Science |
Peer Reviewed | Peer Reviewed |
Volume | 6 |
Issue | 10 |
Article Number | e25333 |
DOI | https://doi.org/10.1371/journal.pone.0025333 |
Keywords | General Biochemistry, Genetics and Molecular Biology; General Agricultural and Biological Sciences; General Medicine |
Public URL | http://researchrepository.napier.ac.uk/id/eprint/5170 |
Publisher URL | http://dx.doi.org/10.1371/journal.pone.0025333 |
Contract Date | Mar 27, 2012 |
Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
(463 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/publicdomain
Copyright Statement
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Evolution and immunopathology of chikungunya virus informs therapeutic development
(2023)
Journal Article
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
(2021)
Journal Article
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search